volume 38 issue 10 pages 1666-1672

Antineoplastic Agents. 291. Isolation and Synthesis of Combretastatins A-4, A-5, and A-6

GeorgeĀ W. Pettit 1
Sheo K. Singh 2
Michael R Boyd 3, 4
Ernest Hamel 3, 4
Robin K. Pettit 5
Jean M. Schmidt 2
FIONA HOGAN 2
Publication typeJournal Article
Publication date1995-05-01
scimago Q1
wos Q1
SJR1.801
CiteScore11.5
Impact factor6.8
ISSN00222623, 15204804
PubMed ID:  7752190
Drug Discovery
Molecular Medicine
Abstract
The antineoplastic constituents of Combretum caffrum (Eckl. and Zeyh) Kuntze (Combretaceae family), a species indigenous to South Africa, have been investigated. Subsequently we isolated a series of closely related bibenzyls, stilbenes, and phenanthrenes from C. caffrum. Some of the stilbenes proved to be potent antimitotic agents which inhibited both tubulin polymerization and the binding of colchicine to tubulin. Combretastatin A-4 has been shown to be the most potent cancer cell growth inhibitor of the series. Presently this cis-stilbene is the most effective inhibitor of colchicine binding to tubulin and the simplest natural product yet described with such potent antitubulin effects. Combretastatin A-4, A-5, and A-6 were also found to inhibit growth of Neisseria gonorrhoeae. Details of the isolation and syntheses of combretastatins A-4 (2a), A-5 (2c), and A-6 (3a) have been described.
Found 

Top-30

Journals

5
10
15
20
25
30
European Journal of Medicinal Chemistry
29 publications, 8.29%
Bioorganic and Medicinal Chemistry
26 publications, 7.43%
Bioorganic and Medicinal Chemistry Letters
26 publications, 7.43%
Tetrahedron
11 publications, 3.14%
Organic and Biomolecular Chemistry
9 publications, 2.57%
Journal of End-to-End-testing
9 publications, 2.57%
Journal of Medicinal Chemistry
8 publications, 2.29%
Tetrahedron Letters
8 publications, 2.29%
Journal of Natural Products
8 publications, 2.29%
Bioorganic Chemistry
7 publications, 2%
Russian Chemical Bulletin
6 publications, 1.71%
Journal of Organic Chemistry
6 publications, 1.71%
Molecules
6 publications, 1.71%
ChemMedChem
6 publications, 1.71%
European Journal of Organic Chemistry
5 publications, 1.43%
Pharmaceuticals
4 publications, 1.14%
Medicinal Chemistry Research
4 publications, 1.14%
Chemistry - A European Journal
4 publications, 1.14%
Angewandte Chemie
4 publications, 1.14%
Angewandte Chemie - International Edition
4 publications, 1.14%
MedChemComm
4 publications, 1.14%
RSC Advances
4 publications, 1.14%
Journal of Ethnopharmacology
3 publications, 0.86%
European Journal of Cancer
3 publications, 0.86%
Acta Crystallographica Section E Structure Reports Online
3 publications, 0.86%
Chemical Biology and Drug Design
3 publications, 0.86%
ChemistrySelect
3 publications, 0.86%
Archiv der Pharmazie
3 publications, 0.86%
Chemical Communications
3 publications, 0.86%
5
10
15
20
25
30

Publishers

20
40
60
80
100
120
140
160
Elsevier
155 publications, 44.29%
Wiley
40 publications, 11.43%
Springer Nature
31 publications, 8.86%
American Chemical Society (ACS)
30 publications, 8.57%
Royal Society of Chemistry (RSC)
25 publications, 7.14%
MDPI
17 publications, 4.86%
Taylor & Francis
15 publications, 4.29%
Georg Thieme Verlag KG
5 publications, 1.43%
Bentham Science Publishers Ltd.
4 publications, 1.14%
International Union of Crystallography (IUCr)
3 publications, 0.86%
SAGE
3 publications, 0.86%
Pleiades Publishing
3 publications, 0.86%
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
2 publications, 0.57%
American Association for Cancer Research (AACR)
2 publications, 0.57%
American Society for Pharmacology and Experimental Therapeutics
1 publication, 0.29%
Pharmaceutical Society of Korea
1 publication, 0.29%
IOP Publishing
1 publication, 0.29%
Public Library of Science (PLoS)
1 publication, 0.29%
Society for Translational Oncology
1 publication, 0.29%
Oxford University Press
1 publication, 0.29%
Walter de Gruyter
1 publication, 0.29%
Baishideng Publishing Group
1 publication, 0.29%
AOSIS
1 publication, 0.29%
20
40
60
80
100
120
140
160
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
350
Share
Cite this
GOST |
Cite this
GOST Copy
Pettit G. et al. Antineoplastic Agents. 291. Isolation and Synthesis of Combretastatins A-4, A-5, and A-6 // Journal of Medicinal Chemistry. 1995. Vol. 38. No. 10. pp. 1666-1672.
GOST all authors (up to 50) Copy
Pettit G., Singh S. K., Boyd M. R., Hamel E., Pettit R. K., Schmidt J. M., HOGAN F. Antineoplastic Agents. 291. Isolation and Synthesis of Combretastatins A-4, A-5, and A-6 // Journal of Medicinal Chemistry. 1995. Vol. 38. No. 10. pp. 1666-1672.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1021/jm00010a011
UR - https://doi.org/10.1021/jm00010a011
TI - Antineoplastic Agents. 291. Isolation and Synthesis of Combretastatins A-4, A-5, and A-6
T2 - Journal of Medicinal Chemistry
AU - Pettit, GeorgeĀ W.
AU - Singh, Sheo K.
AU - Boyd, Michael R
AU - Hamel, Ernest
AU - Pettit, Robin K.
AU - Schmidt, Jean M.
AU - HOGAN, FIONA
PY - 1995
DA - 1995/05/01
PB - American Chemical Society (ACS)
SP - 1666-1672
IS - 10
VL - 38
PMID - 7752190
SN - 0022-2623
SN - 1520-4804
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{1995_Pettit,
author = {GeorgeĀ W. Pettit and Sheo K. Singh and Michael R Boyd and Ernest Hamel and Robin K. Pettit and Jean M. Schmidt and FIONA HOGAN},
title = {Antineoplastic Agents. 291. Isolation and Synthesis of Combretastatins A-4, A-5, and A-6},
journal = {Journal of Medicinal Chemistry},
year = {1995},
volume = {38},
publisher = {American Chemical Society (ACS)},
month = {may},
url = {https://doi.org/10.1021/jm00010a011},
number = {10},
pages = {1666--1672},
doi = {10.1021/jm00010a011}
}
MLA
Cite this
MLA Copy
Pettit, GeorgeĀ W., et al. ā€œAntineoplastic Agents. 291. Isolation and Synthesis of Combretastatins A-4, A-5, and A-6.ā€ Journal of Medicinal Chemistry, vol. 38, no. 10, May. 1995, pp. 1666-1672. https://doi.org/10.1021/jm00010a011.